Texas Capital Bank Wealth Management Services »

Vertex Pharmaceuticals Incorporated shares owned by Texas Capital Bank Wealth Management Services

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Texas Capital Bank Wealth Management Services from 13F filings

Historical chart of Texas Capital Bank Wealth Management Services investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Texas Capital Bank Wealth Management Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Texas Capital Bank Wealth Management Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $213k 429 496.73

More positions owned by Texas Capital Bank Wealth Management Services

Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Apple (AAPL)
Texas Capital Bancshares (TCBI)
Ishares Tr Core S&p Mcp Etf (IJH)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus Mid Cap Etf (IWR)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Lam Research Corp Com New (LRCX)

View all positions for Texas Capital Bank Wealth Management Services

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated